Hasil Pencarian - Simonetta Mocci

  • Menampilkan 1 - 3 hasil dari 3
Perbaiki Hasil
  1. 1
    C-reactive protein reduction post treatment is associated with improved survival in atezolizumab (anti-PD-L1) treated non-small cell lung cancer patients.

    C-reactive protein reduction post treatment is associated with improved survival in atezolizumab (anti-PD-L1) treated non-small cell lung cancer patients. oleh Namrata S Patil, Wei Zou, Simonetta Mocci, Alan Sandler, Marcus Ballinger, Susan Flynn, Marcin Kowanetz, Priti S Hegde

    Diterbitkan 2021-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Concordance Between Tissue ALK Detection by Immunohistochemistry and Plasma ALK Detection by Next-Generation Sequencing in the Randomized Phase 3 ALEX Study in Patients With Treatment-Naive Advanced ALK-Positive NSCLC

    Concordance Between Tissue ALK Detection by Immunohistochemistry and Plasma ALK Detection by Next-Generation Sequencing in the Randomized Phase 3 ALEX Study in Patients With Treatm... oleh Johannes Noé, PhD, Walter Bordogna, PhD, Venice Archer, MD, Vlatka Smoljanovic, MD, Magalie Hilton, MSc, Ryan Woodhouse, BSc, Simonetta Mocci, MD, PhD, Shirish M. Gadgeel, MD

    Diterbitkan 2022-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Laminin-411 is a vascular ligand for MCAM and facilitates TH17 cell entry into the CNS.

    Laminin-411 is a vascular ligand for MCAM and facilitates TH17 cell entry into the CNS. oleh Ken Flanagan, Kent Fitzgerald, Jeanne Baker, Karin Regnstrom, Shyra Gardai, Frederique Bard, Simonetta Mocci, Pui Seto, Monica You, Catherine Larochelle, Alexandre Prat, Samuel Chow, Lauri Li, Chris Vandevert, Wagner Zago, Carlos Lorenzana, Christopher Nishioka, Jennifer Hoffman, Raquel Botelho, Christopher Willits, Kevin Tanaka, Jennifer Johnston, Ted Yednock

    Diterbitkan 2012-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: